Riken Vitamin Co., Ltd.
4526・Prime Market・Foods
Business
Riken Vitamin was founded in 1949, originating from RIKEN (The Institute of Physical and Chemical Research), and is a manufacturer of food ingredients and improving agents. In its Domestic Food Business (approximately 69% of net sales), the company offers Household Food Products (seaweed, dressings, dashi), Commercial-Use Food Products (for restaurants, institutional catering, and convenience stores), and Raw Materials for Processed Foods, etc. (Improving Agents for Food Products, vitamins, natural pigments). In its Domestic Chemical Products & Other Business, the company provides Improving Agents for Chemical Products and additives for feed to the chemical industry. In its Overseas Business, the company sells Improving Agents for Food Products and Improving Agents for Chemical Products through seven bases in North America, Europe, and Asia, centered on its core plant in Malaysia. Major customers span a wide range, including processed food manufacturers, the restaurant and institutional catering industry, convenience stores, and chemical industry manufacturers.
Business Model
With "effective utilization of natural substances" as its technological foundation, the company manufactures Improving Agents for Food Products, vitamins, natural colorants, and Improving Agents for Chemical Products in-house and sells them to BtoB customers, forming the core of its earnings model. Through the A&I Center at the Chiba Plant and application centers at three overseas locations, the company proposes solutions to customers' challenges in product development, quality improvement, and food loss reduction, aiming for a structure that enhances profitability by expanding adoption of high-value-added specialty products.
Company Strengths
The company continues to invest in R&D at 4.1% of net sales (¥3,990 million). It has installed numerous test machines conforming to processed food manufacturers' production equipment at the Chiba Plant A&I Center, establishing a high-precision development system for Improving Agents for Food Products. Its accumulated proprietary technologies in the seaweed field—including wakame seedling selection technology, land-based aquaculture, and blue carbon research—also constitute unique assets that are difficult for competitors to imitate in the short term.
For FY2026 (ending March 2026), the company maintains an equity ratio of 71.6%, cash and cash equivalents of ¥19,131 million, and free cash flow of ¥7,711 million. With three segments—Domestic Food Business, Chemical Products, and Overseas Business—the stable earnings generated by the two domestic businesses underpin its financial position. A ¥6,000 million commitment line agreement with domestic financial institutions also supplements liquidity.
The company operates 7 sales subsidiaries across North America, Europe, Southeast Asia, China, and Taiwan, and has built a global supply chain centered on its core manufacturing plant in Malaysia. Three application centers in Singapore, Shanghai, and the United States provide technical services tailored to local customer needs, and in 2025 new bases in Vietnam and Thailand were also consolidated.
ENVALITH's Perspective
Performance Trend
Net sales reached ¥96,300 million (up 0.8% year on year), marking five consecutive years of revenue growth, but the growth rate slowed significantly. Operating profit came to ¥6,900 million (down 20.9% year on year), declining for the second consecutive period and falling 26.4% from the peak of ¥9,371 million recorded in FY2024 (ended March 2024). The decline in profit was attributable to: (1) a temporary reduction of ¥891 million due to a change in the estimate of asbestos removal costs; (2) the Overseas Business falling into an operating loss (a deterioration of ¥1,556 million year on year); and (3) increases in labor costs and depreciation expenses. As external factors, weakening consumer sentiment amid continued price increases and a gradual slowdown in the Chinese economy affected earnings both overseas and domestically. Net income attributable to owners of the parent was ¥7,035 million (down 25.1% year on year). Comprehensive income was ¥9,553 million (up 47.9% year on year), aided by an improvement in the foreign currency translation adjustment account.
Growth Strategy
Advancing the second year of the Medium-Term Management Plan 2027 through two pillars: strengthening the domestic structure and building a new overseas structure
Continuing to promote price revisions in response to rising labor costs and depreciation expenses. Maintaining and expanding the sales and profit base of the Domestic Food Business, centered on strengthening proposals for Improving Agents for Food Products and growth of functional food ingredients within Raw Materials for Processed Foods, etc., and acquiring new demand from restaurants and convenience stores for Commercial-Use Food Products. In FY2026 (ending March 2026), secured Domestic Food Business sales of ¥66,360 million (up 2.4% year on year).
Strengthening the Asian sales structure through the new consolidation of Thailand (RIKEVITA (THAILAND) CO., LTD.) and Vietnam (RIKEVITA VIET NAM CO., LTD.), while promoting expanded adoption by major customers and growth in extract products in North America. Aiming to shift toward specialty products in response to intensifying competition in general-purpose products in China, Europe, and Southeast Asia. In FY2026 (ending March 2026), the segment fell into an operating loss of ¥436 million, making an early return to profitability an urgent priority.
Continuing to implement the capital investment plan under Medium-Term Management Plan 2027 (cumulative ¥25,000 million over three years). In FY2026 (ending March 2026), the increase in tangible and intangible fixed assets was ¥6,606 million, and depreciation expenses were ¥4,677 million (a significant increase from ¥3,204 million in the previous fiscal year). The challenge is to absorb the rising fixed costs through the realization of investment effects and translate this into improved profitability.
Annual dividend for FY2026 (ending March 2026) was ¥110 (increased from ¥94 in the previous fiscal year), with a payout ratio of 46.2%. As a subsequent event, share buybacks of up to ¥2,000,000,000 and 900,000 shares are planned to be conducted between June and September 2026. For FY2027 (ending March 2027), an annual dividend of ¥110 and a payout ratio of 42.8% are forecast, indicating an intention to maintain the level of shareholder returns regardless of the profit level.
Last updated: July 19, 2026